1.40
0.05 (3.7%)
0.05 (3.7%)
Upgrade to Real-Time
Market Closed
Low
0.652
High
2.54
Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Canna Trader Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Northwest Biotherapeutics Inc (QB) | NWBO | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.05 | 3.7% | 1.40 | 16:03:45 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.35 | 1.35 | 1.43 | 1.40 | 1.35 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 1.39 | 1.42 | 0.03 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,518 | 2,719,848 | $ 1.408 | $ 3,829,421 | - | 0.652 - 2.54 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:01:32 | formt | 1,336 | $ 1.40 | USD |
Period:
Draw Mode:
Northwest Biotherapeutics Inc (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.22B | 870.33M | 657.93M | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 19.12M | $ - | - | - | - |
Northwest Biotherapeutics (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NWBO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.22 | 1.43 | 1.20 | 1.29 | 1,067,378 | 0.18 | 14.75% |
| 1 Month | 1.24 | 1.47 | 1.14 | 1.28 | 1,071,873 | 0.16 | 12.9% |
| 3 Months | 1.46 | 1.54 | 1.02 | 1.27 | 1,271,725 | -0.06 | -4.11% |
| 6 Months | 1.63 | 2.15 | 1.02 | 1.45 | 1,565,487 | -0.23 | -14.11% |
| 1 Year | 0.935 | 2.54 | 0.652 | 1.41 | 3,056,804 | 0.465 | 49.73% |
| 3 Years | 0.19 | 2.54 | 0.005 | 0.83785 | 2,184,935 | 1.21 | 636.84% |
| 5 Years | 0.5275 | 2.54 | 0.005 | 0.6553475 | 1,997,224 | 0.8725 | 165.4% |
Northwest Biotherapeutics (QB) Description
| Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. The Company operates in the United States, the UK, Germany and Canada and is incorporated in Delaware, USA. |
